Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2009-06-29
Original market date: See footnote 1
1998-12-08
Product name:
MAALOX HRF SUSPENSION
DIN:
02238388 Electronic product monograph is not available
Company:
NOVARTIS CONSUMER HEALTH CANADA INC.
500
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:04.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A02BX13 ALGINIC ACID
Active ingredient group (AIG) number:See footnote5
0331861002
Active ingredient(s) See footnote8 | Strength |
---|---|
CALCIUM CARBONATE | 300 MG / 5 ML |
MAGNESIUM CARBONATE | 125 MG / 5 ML |
SODIUM ALGINATE | 275 MG / 5 ML |